Literature DB >> 2531046

Abnormal subendocardial blood flow in pressure overload hypertrophy is associated with pacing-induced subendocardial dysfunction.

K Nakano1, W J Corin, J F Spann, R W Biederman, S Denslow, B A Carabello.   

Abstract

To detect the functional significance of subendocardial hypoperfusion in the pressure-overloaded left ventricle, we studied subendocardial and subepicardial function and subendocardial and subepicardial blood flow simultaneously in seven dogs with left ventricular hypertrophy (left ventricle/body weight ratio, 7.2 g/kg) produced by chronic aortic banding. Seven normal dogs served as controls. Subendocardial and subepicardial segment lengths were measured by ultrasonic dimension gauges, and myocardial blood flow was measured with radioactive microspheres. Atrial pacing (180-200 beats/min for 5 minutes) was used to produce a chronotropic stress. In dogs with left ventricular hypertrophy, the subendocardial blood flow failed to increase during pacing compared with the baseline state (1.21 +/- 0.17 vs. 1.22 +/- 0.17 ml/min/g). Subendocardial shortening fraction deteriorated with pacing stress (before pacing, 30.6 +/- 3.9%; after pacing, 24.2 +/- 3.7%; p less than 0.001). In controls, subendocardial blood flow increased from 1.32 +/- 0.19 to 1.80 +/- 0.19 ml/min/g during pacing, and shortening fraction was preserved (before pacing, 25.5 +/- 3.9%; after pacing, 25.9 +/- 3.3%). Subepicardial blood flow in dogs with hypertrophy increased from 1.54 +/- 0.24 to 2.32 +/- 0.34 ml/min/g, and subepicardial shortening fraction was maintained (before pacing, 10.4 +/- 1.0%; after pacing, 10.5 +/- 1.2%) as it was in controls (subepicardial blood flow, from 1.27 +/- 0.18 to 2.12 +/- 0.17 ml/min/g; shortening fraction, from 16.6 +/- 2.5% to 15.5 +/- 2.2%). We conclude that, with pacing stress in pressure-overload hypertrophy, subendocardial blood flow failed to increase. This abnormality corresponded with a deterioration in subendocardial contractile function.

Entities:  

Mesh:

Year:  1989        PMID: 2531046     DOI: 10.1161/01.res.65.6.1555

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  6 in total

1.  LV reverse remodeling imparted by aortic valve replacement for severe aortic stenosis; is it durable? A cardiovascular MRI study sponsored by the American Heart Association.

Authors:  Robert W W Biederman; James A Magovern; Saundra B Grant; Ronald B Williams; June A Yamrozik; Diane A Vido; Vikas K Rathi; Geetha Rayarao; Ketheswaram Caruppannan; Mark Doyle
Journal:  J Cardiothorac Surg       Date:  2011-04-14       Impact factor: 1.637

Review 2.  Assessment and management of aortic valve disease in patients with left ventricular dysfunction.

Authors:  Mackram F Eleid; Sunil Mankad; Paul Sorajja
Journal:  Heart Fail Rev       Date:  2013-01       Impact factor: 4.214

3.  Mechanisms of regional ischaemic changes during dipyridamole echocardiography in patients with severe aortic valve stenosis and normal coronary arteries.

Authors:  M Baroni; S Maffei; M Terrazzi; C Palmieri; F Paoli; A Biagini
Journal:  Heart       Date:  1996-05       Impact factor: 5.994

Review 4.  Cardiomyocyte Proliferation from Fetal- to Adult- and from Normal- to Hypertrophy and Failing Hearts.

Authors:  Sanford P Bishop; Jianyi Zhang; Lei Ye
Journal:  Biology (Basel)       Date:  2022-06-08

5.  Clinical correlates and prognostic significance of change in standardized left ventricular mass in a community-based cohort of African Americans.

Authors:  Ervin R Fox; Solomon K Musani; Tandaw E Samdarshi; Jared K Taylor; Walter L Beard; Daniel F Sarpong; Vanessa Xanthakis; Eric E McClendon; Philip R Liebson; Thomas N Skelton; Kenneth R Butler; Thomas H Mosley; Herman Taylor; Ramachandran S Vasan
Journal:  J Am Heart Assoc       Date:  2015-02-05       Impact factor: 5.501

6.  Increased stiffness is the major early abnormality in a pig model of severe aortic stenosis and predisposes to congestive heart failure in the absence of systolic dysfunction.

Authors:  Kiyotake Ishikawa; Jaume Aguero; Jae Gyun Oh; Nadjib Hammoudi; Lauren A Fish; Lauren Leonardson; Belén Picatoste; Carlos G Santos-Gallego; Kenneth M Fish; Roger J Hajjar
Journal:  J Am Heart Assoc       Date:  2015-05-20       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.